67 related articles for article (PubMed ID: 22066687)
1. The influence of pre-admission hypoglycaemic therapy on cardiac morbidity and mortality in type 2 diabetic patients undergoing major non-cardiac surgery: a prospective observational study.
Bolliger D; Seeberger MD; Lurati Buse G; Christen P; Seeberger E; Ruppen W; Filipovic M
Anaesthesia; 2012 Feb; 67(2):149-57. PubMed ID: 22066687
[TBL] [Abstract][Full Text] [Related]
2. Oral hypoglycemics: increased postoperative mortality in coronary risk patients.
Jeger RV; Seeberger MD; Keller U; Pfisterer ME; Filipovic M
Cardiology; 2007; 107(4):296-301. PubMed ID: 17264509
[TBL] [Abstract][Full Text] [Related]
3. Impact of glycaemic control, hypertension and insulin treatment on general and cause-specific mortality: an Italian population-based cohort of type II (non-insulin-dependent) diabetes mellitus.
Bruno G; Merletti F; Boffetta P; Cavallo-Perin P; Bargero G; Gallone G; Pagano G
Diabetologia; 1999 Mar; 42(3):297-301. PubMed ID: 10096781
[TBL] [Abstract][Full Text] [Related]
4. Neither diabetes nor glucose-lowering drugs are associated with mortality after noncardiac surgery in patients with coronary artery disease or heart failure.
Hanninen M; McAlister FA; Bakal JA; van Diepen S; Ezekowitz JA
Can J Cardiol; 2013 Apr; 29(4):423-8. PubMed ID: 22985785
[TBL] [Abstract][Full Text] [Related]
5. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
Savage S; Estacio RO; Jeffers B; Schrier RW
Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
[TBL] [Abstract][Full Text] [Related]
6. Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy.
Schmeltz LR; DeSantis AJ; Thiyagarajan V; Schmidt K; O'Shea-Mahler E; Johnson D; Henske J; McCarthy PM; Gleason TG; McGee EC; Molitch ME
Diabetes Care; 2007 Apr; 30(4):823-8. PubMed ID: 17229943
[TBL] [Abstract][Full Text] [Related]
7. Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure.
Smooke S; Horwich TB; Fonarow GC
Am Heart J; 2005 Jan; 149(1):168-74. PubMed ID: 15660049
[TBL] [Abstract][Full Text] [Related]
8. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
[TBL] [Abstract][Full Text] [Related]
9. Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group.
Gustafsson I; Hildebrandt P; Seibaek M; Melchior T; Torp-Pedersen C; Køber L; Kaiser-Nielsen P
Eur Heart J; 2000 Dec; 21(23):1937-43. PubMed ID: 11071799
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort.
Dornhorst A; Lüddeke HJ; Sreenan S; Koenen C; Hansen JB; Tsur A; Landstedt-Hallin L
Int J Clin Pract; 2007 Mar; 61(3):523-8. PubMed ID: 17313628
[TBL] [Abstract][Full Text] [Related]
11. [Postoperative cardiac morbidity/mortality in high-risk elderly patients undergoing non-cardiac surgery].
de la Cruz Pérez C; Estecha Foncea MA; Cruz Mañas J; Castillo Caparrós A; Palma Pérez F; Sarmiento Pardo J
Rev Esp Anestesiol Reanim; 1999 Jan; 46(1):4-8. PubMed ID: 10073077
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with switching from oral hypoglycaemic agents to insulin therapy.
Spoelstra JA; Stol RP; de Bruyne MC; Erkens JA; Herings RM; Leufkens HG; Grobbee DE
Neth J Med; 2002 Jul; 60(6):243-8. PubMed ID: 12365467
[TBL] [Abstract][Full Text] [Related]
13. The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes.
Khalangot M; Tronko M; Kravchenko V; Kulchinska J; Hu G
Diabetes Res Clin Pract; 2008 Oct; 82(1):139-47. PubMed ID: 18703252
[TBL] [Abstract][Full Text] [Related]
14. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
[TBL] [Abstract][Full Text] [Related]
15. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
[TBL] [Abstract][Full Text] [Related]
16. Hypoglycemia in diabetic patients undergoing chronic hemodialysis.
Sun CY; Lee CC; Wu MS
Ther Apher Dial; 2009 Apr; 13(2):95-102. PubMed ID: 19379147
[TBL] [Abstract][Full Text] [Related]
17. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
[TBL] [Abstract][Full Text] [Related]
18. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
Fischer JS; McLaughlin T; Loza L; Beauchamp R; Schwartz S; Kipnes M
Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
[TBL] [Abstract][Full Text] [Related]
19. Are sulphonylureas all the same? A cohort study on cardiovascular and cancer-related mortality.
Monami M; Balzi D; Lamanna C; Barchielli A; Masotti G; Buiatti E; Marchionni N; Mannucci E
Diabetes Metab Res Rev; 2007 Sep; 23(6):479-84. PubMed ID: 17385195
[TBL] [Abstract][Full Text] [Related]
20. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study.
Donnelly LA; Morris AD; Frier BM; Ellis JD; Donnan PT; Durrant R; Band MM; Reekie G; Leese GP;
Diabet Med; 2005 Jun; 22(6):749-55. PubMed ID: 15910627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
